TEVA B1 Pill: yellow, round, 6mm
The pill with imprint TEVA B1 (Yellow, Round, 6mm) has been identified as Letrozole 2.5 mg and is used for Breast Cancer, Metastatic, Breast Cancer, Adjuvant, and Breast Cancer. It belongs to the drug classes aromatase inhibitors, hormones/antineoplastics and is not a controlled substance.
Images for TEVA B1
Letrozole
- Imprint
- TEVA B1
- Strength
- 2.5 mg
- Color
- Yellow
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc
- Inactive Ingredients
-
silicon dioxide,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Yellow No. 5,
ferric oxide yellow,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 3350,
polyethylene glycol 4000,
sodium starch glycolate type A potato,
corn starch,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7620 | Teva Pharmaceuticals USA, Inc. |
| 42291-0374 | AvKare, Inc. |
See also:
More about letrozole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (368)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: aromatase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.